Grenier, J. L., E. Toth, G. De Serres, S. Menard, R. Roussel, M. Tremblay, M. Landry, Y. Robert, and D. M. Skowronski. 2004. Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination. Canada Communicable Disease Report 30(2):9-16.

Hull, J. H. K., S. H. Mead, O. J. Foster, and H. Modarres-Sadeghi. 2004. Severe vasculitic neuropathy following influenza vaccination. Journal of Neurology, Neurosurgery and Psychiatry 75(10):1507-1508.

Kaplanski, G., F. Retornaz, J. Durand, and J. Soubeyrand. 1995. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. Journal of Neurology, Neurosurgery and Psychiatry 58(6):758-759.

Knight, R. S. G., J. S. Duncan, C. J. F. Davis, and C. P. Warlow. 1984. Influenza vaccination and Guillain-Barré syndrome. Lancet 1(8373):394.

Kuruma, K. A. M., E. F. Borba, M. H. Lopes, J. F. de Carvalho, and E. Bonfa. 2007. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 16(5):350-354.

Lear, J. T., and J. S. English. 1995. Anaphylaxis after hepatitis B vaccination. Lancet 345(8959): 1249.

Miller, D., J. Wadsworth, J. Diamond, and E. Ross. 1997. Measles vaccination and neurological events. Lancet 349(9053):730-731.

Morris, K., and G. Rylance. 1994. Guillain-Barré syndrome after measles, mumps, and rubella vaccine. Lancet 343(8888):60.

Nadler, J. P. 1993. Multiple sclerosis and hepatitis B vaccination. Clinical Infectious Diseases 17(5):928-929.

National Advisory Committee on Immunization. 2001. Statement on influenza vaccination for the 2001-2002 season. Canada Communicable Disease Report 27(4):1-24.

Perumalswami, P., L. Peng, and J. A. Odin. 2009. Vaccination as a triggering event for autoimmune hepatitis. Seminars in Liver Disease 29(3):331-334.

Plesner, A. M. 1995. Gait disturbances after measles, mumps, and rubella vaccine. Lancet 345(8945):316.

Pritchard, J., R. Mukherjee, and R. A. C. Hughes. 2002. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. Journal of Neurology, Neurosurgery, and Psychiatry 73(3):348-349.

Read, S. J., G. J. Schapel, and M. P. Pender. 1992. Acute transverse myelitis after tetanus toxoid vaccination. Lancet 339(8801):1111-1112.

Reijneveld, J. C., M. J. B. Taphoorn, T. U. Hoogenraad, and J. Van Gijn. 1997. Severe but transient parkinsonism after tetanus vaccination. Journal of Neurology Neurosurgery and Psychiatry 63(2):258.

Schneck, S. A., V. Fulginiti, and J. Leestma. 1967. Measles virus and panencephalitis. Lancet 1(7504):1381-1382.

Shapiro, E., and J. K. Burd. 2000. Comment on the article “Can immunization precipitate connective tissue disease? Report of 5 cases of systemic lupus erythematosus and review of the literature.” Seminars in Arthritis and Rheumatism 30(3):215-216.

Stratta, P., R. Cremona, E. Lazzarich, M. Quaglia, R. Fenoglio, and C. Canavese. 2008. Life-threatening systemic flare-up of systemic lupus erythematosus following influenza vaccination. Lupus 17(1):67-68.

Tingle, A. J., C. H. Pot, and J. K. Chantler. 1984. Prolonged arthritis, viraemia, hypo-gammaglobulinaemia, and failed seroconversion following rubella immunisation. Lancet 323(8392):1475-1476.

Topaloglu, H., M. Berker, T. Kansu, U. Saatci, and Y. Renda. 1992. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet 339(8786):178-179.

Winer, J. B., R. A. C. Hughes, G. W. Bradley, and J. W. Scadding. 1984. Guillain-Barré syndrome and influenza vaccine. Lancet 1(8387):1182.

Woo, E. J., R. Ball, and M. Miles Braun. 2005. Fatal syncope-related fall after immunization. Archives of Pediatrics and Adolescent Medicine 159(11):1083.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement